Join Now

Category Archives: Industry News

RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System

By Denise Bell | Published September 18, 2020

Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the Mount Sinai Health System. This means that KidneyIntelX risk assessment of progressive decline in kidney function or kidney failure, including education support for treating clinicians, is now commercially available for patients with early stage diabetic kidney disease […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

2020 Bench to Bedside Participants Announced

By admin | Published September 18, 2020

Courtesy of University of Utah Academics & Research Postponed from its original in-person event last April, the annual medical innovation challenge has moved entirely online this year. Tuesday September 8, 2020 | Salt Lake City, UT Nearly five months after postponing the original in-person event in response to COVID-19, the 10th Annual Bench to Bedside competition […]

| Leave a comment

BioUtah Member Horizon Therapeutics Named to PEOPLE’s “50 Companies That Care” List

By Denise Bell | Published September 11, 2020

Horizon Therapeutics has been named to PEOPLE’s 2020 “50 Companies That Care” list. Partnering with Great Place to Work, PEOPLE identified the top U.S. companies that went above and beyond in responding to the pandemic.The list, focused on employers with 1,000 or more employees, will be featured in the Sept. 14, 2020 print issue of […]

| Leave a comment

Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic Diseases

By admin | Published September 11, 2020

By Chris Gibson, PhD via Recursion – Drug discovery partnership and equity investment led by Leaps by Bayer in Series D financing round – Digitally-powered drug discovery to address fibrotic diseases with previously undiscovered mechanisms and to deliver novel therapies to patients faster Berlin, Germany and Salt Lake City, USA, September 9, 2020 – Bayer and […]

Also posted in Life Sciences Industry News | | Leave a comment

BioUtah and Utah Biotech/Biopharma Companies Raise Concerns About Impact of Trump’s “Most-Favored-Nation” Drug Pricing Order on Innovation

By admin | Published August 19, 2020

BioUtah, along with 10 Utah biotech and biopharma companies, have sent letters to Utah’s U.S. Senators and Representatives urging opposition to the President’s directive to impose “most-favored nation” pricing on Medicare Part B drugs. The letter notes that if the executive order moves forward, investment dollars for Utah’s smaller drug discovery companies could dry up […]

Also posted in Policy News | | Leave a comment

BioUtah Statement on Launch of Altitude Lab, Largest Life Sciences Incubator in Utah

By admin | Published August 12, 2020

Recursion and University of Utah found incubator to propel new generation of life sciences in the region August 12, 2020 04:18 PM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–BioUtah President and CEO, Kelvyn Cullimore, issued the following statement following the announcement of the opening of Altitude Lab. “This is truly a life sciences milestone in […]

Also posted in BioUtah News, Life Sciences Industry News | | Leave a comment

Recap of Stock Market Update with Monica DiCenso of JP Morgan

By admin | Published July 22, 2020

After leaving quite an impression to the attendees of the 2020 Entrepreneur and Investor Summit, we brought Monica DiCenso, managing director and head of Global Investment Opportunities Group at J.P. Morgan, back for a mid-year update on the stock market. In the webinar, Ms. Dicenso provided important insight into the rebound of the economy since […]

Also posted in BioUtah News, Life Sciences Events | | Leave a comment

Initial Data for Moderna COVID-19 Vaccine Shows Promise

By Denise Bell | Published July 17, 2020

On Tuesday, Moderna announced promising results from the Phase 1 study of its vaccine candidate, called mRNA-1273. The study, published in The New England Journal of Medicine  showed that all 45 volunteers who received two vaccine doses developed immune responses that were stronger than in patients who have recovered from COVID-19. “These positive Phase 1 […]

Also posted in Federal News | | Leave a comment

BioFire Respiratory Panel with COVID Target Scores CE Mark

By Denise Bell | Published July 17, 2020

BioMerieux announced that Utah-based BioFire’s Respiratory Panel 2.1 plus, which tests for SARS-CoV-2 and 23 pathogens encompassing 19 viruses, and four bacteria that cause the most frequent respiratory tract infections, has received CE marking.  “It’s exciting to see the advances that BioFire is making in COVID-19 and infectious disease diagnostics,” said Kelvyn Cullimore, president and […]

Also posted in BioUtah News, Federal News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

Pfizer, BioNTech Get FDA Fast Track Status for COVID-19 Vaccines

By Denise Bell | Published July 17, 2020

U.S. Pfizer and Germany’s BioNTech announced Monday that they have received Fast Track designation from the FDA for two COVID-19 vaccine candidates – BNT162b1 and BNT162b2 – part of the companies’ “Project Lightspeed” program. The designation was issued based on promising preliminary data from Phase 1/2 clinical studies. The FDA’s Fast Track designation is intended […]

Also posted in BioUtah News, COVID-19 Updates, Federal News | | Leave a comment

A Special Thanks To Our Elite Members